vs
COLLEGIUM PHARMACEUTICAL, INC（COLL）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
Rapid7, Inc.的季度营收约是COLLEGIUM PHARMACEUTICAL, INC的1.1倍（$217.4M vs $205.4M），COLLEGIUM PHARMACEUTICAL, INC净利率更高（8.3% vs 1.4%，领先6.8%），COLLEGIUM PHARMACEUTICAL, INC同比增速更快（12.9% vs 0.5%），COLLEGIUM PHARMACEUTICAL, INC自由现金流更多（$122.4M vs $36.4M），过去两年COLLEGIUM PHARMACEUTICAL, INC的营收复合增速更高（19.1% vs 3.0%）
Collegium制药是一家专科制药企业，专注于研发和商业化具备滥用威慑特性的创新疼痛管理疗法，主要面向美国市场，推出适用于慢性疼痛患者的缓释镇痛产品，服务覆盖基层及专科医疗领域的医护人员。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
COLL vs RPD — 直观对比
营收规模更大
RPD
是对方的1.1倍
$205.4M
营收增速更快
COLL
高出12.4%
0.5%
净利率更高
COLL
高出6.8%
1.4%
自由现金流更多
COLL
多$85.9M
$36.4M
两年增速更快
COLL
近两年复合增速
3.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $205.4M | $217.4M |
| 净利润 | $17.0M | $3.1M |
| 毛利率 | 62.5% | 68.9% |
| 营业利润率 | 29.6% | 1.0% |
| 净利率 | 8.3% | 1.4% |
| 营收同比 | 12.9% | 0.5% |
| 净利润同比 | 35.3% | 44.1% |
| 每股收益（稀释后） | $0.48 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COLLRPD
| Q4 25 | $205.4M | $217.4M | ||
| Q3 25 | $209.4M | $218.0M | ||
| Q2 25 | $188.0M | $214.2M | ||
| Q1 25 | $177.8M | $210.3M | ||
| Q4 24 | $181.9M | $216.3M | ||
| Q3 24 | $159.3M | $214.7M | ||
| Q2 24 | $145.3M | $208.0M | ||
| Q1 24 | $144.9M | $205.1M |
净利润COLLRPD
| Q4 25 | $17.0M | $3.1M | ||
| Q3 25 | $31.5M | $9.8M | ||
| Q2 25 | $12.0M | $8.3M | ||
| Q1 25 | $2.4M | $2.1M | ||
| Q4 24 | $12.5M | $2.2M | ||
| Q3 24 | $9.3M | $15.4M | ||
| Q2 24 | $19.6M | $6.5M | ||
| Q1 24 | $27.7M | $1.4M |
毛利率COLLRPD
| Q4 25 | 62.5% | 68.9% | ||
| Q3 25 | 61.7% | 70.2% | ||
| Q2 25 | 57.7% | 70.6% | ||
| Q1 25 | 54.8% | 71.7% | ||
| Q4 24 | 54.0% | 69.5% | ||
| Q3 24 | 60.8% | 70.6% | ||
| Q2 24 | 62.5% | 70.7% | ||
| Q1 24 | 63.1% | 70.3% |
营业利润率COLLRPD
| Q4 25 | 29.6% | 1.0% | ||
| Q3 25 | 29.7% | 2.7% | ||
| Q2 25 | 18.7% | 1.6% | ||
| Q1 25 | 12.2% | -0.0% | ||
| Q4 24 | 20.9% | 3.4% | ||
| Q3 24 | 21.9% | 6.0% | ||
| Q2 24 | 32.7% | 2.5% | ||
| Q1 24 | 34.1% | 4.7% |
净利率COLLRPD
| Q4 25 | 8.3% | 1.4% | ||
| Q3 25 | 15.0% | 4.5% | ||
| Q2 25 | 6.4% | 3.9% | ||
| Q1 25 | 1.4% | 1.0% | ||
| Q4 24 | 6.9% | 1.0% | ||
| Q3 24 | 5.9% | 7.2% | ||
| Q2 24 | 13.5% | 3.1% | ||
| Q1 24 | 19.1% | 0.7% |
每股收益（稀释后）COLLRPD
| Q4 25 | $0.48 | $0.05 | ||
| Q3 25 | $0.84 | $0.15 | ||
| Q2 25 | $0.34 | $0.13 | ||
| Q1 25 | $0.07 | $0.03 | ||
| Q4 24 | $0.36 | $0.08 | ||
| Q3 24 | $0.27 | $0.21 | ||
| Q2 24 | $0.52 | $0.09 | ||
| Q1 24 | $0.71 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $386.7M | $474.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $301.7M | $154.7M |
| 总资产 | $1.7B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资COLLRPD
| Q4 25 | $386.7M | $474.7M | ||
| Q3 25 | $285.9M | $407.1M | ||
| Q2 25 | $222.2M | $511.7M | ||
| Q1 25 | $197.8M | $493.5M | ||
| Q4 24 | $162.8M | $521.7M | ||
| Q3 24 | $120.0M | $443.7M | ||
| Q2 24 | $271.6M | $442.6M | ||
| Q1 24 | $318.0M | $411.7M |
股东权益COLLRPD
| Q4 25 | $301.7M | $154.7M | ||
| Q3 25 | $274.8M | $127.2M | ||
| Q2 25 | $232.2M | $90.4M | ||
| Q1 25 | $234.4M | $52.7M | ||
| Q4 24 | $228.8M | $17.7M | ||
| Q3 24 | $234.3M | $-5.1M | ||
| Q2 24 | $216.6M | $-52.6M | ||
| Q1 24 | $222.2M | $-86.4M |
总资产COLLRPD
| Q4 25 | $1.7B | $1.7B | ||
| Q3 25 | $1.6B | $1.7B | ||
| Q2 25 | $1.6B | $1.6B | ||
| Q1 25 | $1.6B | $1.6B | ||
| Q4 24 | $1.7B | $1.7B | ||
| Q3 24 | $1.6B | $1.6B | ||
| Q2 24 | $1.1B | $1.5B | ||
| Q1 24 | $1.1B | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $123.0M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | $122.4M | $36.4M |
| 自由现金流率自由现金流/营收 | 59.6% | 16.8% |
| 资本支出强度资本支出/营收 | 0.3% | 0.5% |
| 现金转化率经营现金流/净利润 | 7.25× | 12.01× |
| 过去12个月自由现金流最近4个季度 | $327.6M | $146.2M |
8季度趋势，按日历期对齐
经营现金流COLLRPD
| Q4 25 | $123.0M | $37.6M | ||
| Q3 25 | $78.4M | $39.0M | ||
| Q2 25 | $72.4M | $47.5M | ||
| Q1 25 | $55.4M | $29.8M | ||
| Q4 24 | $84.6M | $63.8M | ||
| Q3 24 | $-9.0M | $44.0M | ||
| Q2 24 | $67.4M | $32.9M | ||
| Q1 24 | $61.9M | $31.1M |
自由现金流COLLRPD
| Q4 25 | $122.4M | $36.4M | ||
| Q3 25 | $78.3M | $34.8M | ||
| Q2 25 | $72.4M | $46.6M | ||
| Q1 25 | $54.6M | $28.4M | ||
| Q4 24 | $84.1M | $62.6M | ||
| Q3 24 | $-9.2M | $42.6M | ||
| Q2 24 | $67.1M | $32.6M | ||
| Q1 24 | $61.4M | $30.4M |
自由现金流率COLLRPD
| Q4 25 | 59.6% | 16.8% | ||
| Q3 25 | 37.4% | 16.0% | ||
| Q2 25 | 38.5% | 21.8% | ||
| Q1 25 | 30.7% | 13.5% | ||
| Q4 24 | 46.2% | 28.9% | ||
| Q3 24 | -5.8% | 19.9% | ||
| Q2 24 | 46.2% | 15.7% | ||
| Q1 24 | 42.3% | 14.8% |
资本支出强度COLLRPD
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 0.1% | 1.9% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 0.3% | 0.5% | ||
| Q3 24 | 0.2% | 0.6% | ||
| Q2 24 | 0.2% | 0.1% | ||
| Q1 24 | 0.4% | 0.3% |
现金转化率COLLRPD
| Q4 25 | 7.25× | 12.01× | ||
| Q3 25 | 2.49× | 3.97× | ||
| Q2 25 | 6.05× | 5.70× | ||
| Q1 25 | 22.92× | 14.14× | ||
| Q4 24 | 6.75× | 29.36× | ||
| Q3 24 | -0.96× | 2.85× | ||
| Q2 24 | 3.44× | 5.03× | ||
| Q1 24 | 2.23× | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COLL
暂无分部数据
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
